Early diagnosis and treatment of rheumatoid arthritis improves long-term outcomes and reduces or halts joint damage progression. However, delays at the patient and medical system levels remain a barrier to early diagnosis and therapy, despite the presence of early arthritis clinics designed to expedite treatment.
References
McInnes, I. B. & O'Dell, J. R. State-of-the-art: rheumatoid arthritis. Ann. Rheum. Dis. 69, 1898–1906 (2010).
Hazesm J. M. & Luime, J. J. The epidemiology of early inflammatory arthritis. Nature Rev. Rheumatol. 7, 381–390 (2011).
Goëb, V., Smolen, J., Emery, P. & Marzo-Ortega, H. Early inflammatory clinics. Experience with early arthritis/back pain clinics. Clin. Exp. Rheumatol. 27 (Suppl. 55), S74–S79 (2009).
Stack, R. J. et al. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ard.2011.155416.
Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).
Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580–1588 (2010).
Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964–975 (2010).
van der Linden, M. P., Knevel, R., Huizinga, T. W. & van der Helm-van Mil, A. H. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum. 63, 37–42 (2011).
van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 91–98 (2011).
Olivieri, I. et al. Early treatment in early undifferentiated arthritis. Autoimmun. Rev. http://dx.doi.org/10.1016/j.autrev.2011.10.019
Acknowledgements
We wish to acknowledge Dr Kevin Smart for language support ahead of submission.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Atzeni, F., Sarzi-Puttini, P. Why wait? Explaining delays in seeking therapy for early arthritis. Nat Rev Rheumatol 8, 190–191 (2012). https://doi.org/10.1038/nrrheum.2012.24
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.24
- Springer Nature Limited
This article is cited by
-
A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
Pain and Therapy (2018)